Curated News
By: NewsRamp Editorial Staff
May 07, 2024
New Study Shows Cardio Diagnostics NASDAQ CDIO PrecisionCHD Test Could Save Health Insurers Over $113 Million Annually
Discuss on Reddit
Discuss on SubstackTLDR
- PrecisionCHD offers significant cost savings for patients and payers, potentially saving $113.6 million per year.
- PrecisionCHD is an integrated genetic-epigenetic test for the detection of coronary heart disease, using six DNA methylation and ten genetic biomarkers.
- PrecisionCHD's cost-efficient and scalable alternative for CHD detection testing can lead to increased access to care and improved outcomes for patients.
- PrecisionCHD, an AI-powered cardiovascular medicine, offers an innovative, cost-efficient, and less resource-intensive approach to detecting and managing coronary heart disease.
Impact - Why it Matters
Heart disease remains the leading cause of death among Americans, and the barriers to obtaining early cardiovascular care could lead to increased prevalence and costs. PrecisionCHD offers a more cost-efficient, less resource-intensive, and highly scalable alternative for initial CHD detection testing, potentially revolutionizing how coronary heart disease is diagnosed and managed. The study's findings have the potential to increase access to care, improve outcomes for patients with CHD, and drive value for healthcare stakeholders.
Summary
Cardio Diagnostics (NASDAQ: CDIO) has announced the publication of results from a budget impact modeling study for its leading clinical product, PrecisionCHD. The study highlights the test’s promising developments and suggests significant cost savings for patients, with an estimated $113.6 million saved per year for a plan with one million members. PrecisionCHD, an integrated genetic-epigenetic test for the detection of coronary heart disease, was recently awarded the Current Procedural Terminology (CPT) code and the Innovation Technology contract from Vizient.
Source Statement
This curated news summary relied on this press release disributed by News Direct. Read the source press release here, New Study Shows Cardio Diagnostics NASDAQ CDIO PrecisionCHD Test Could Save Health Insurers Over $113 Million Annually
